Asia Pacific Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
The Asia Pacific donor blood component market is projected to grow significantly, reaching an estimated US$ 1,878.3 million by 2031, up from US$ 1,262.3 million in 2024, reflecting a compound annual growth rate (CAGR) of 6.0% from 2025 to 2031. This growth is driven by several factors, including rapid population growth, increasing incidences of chronic diseases, and advancements in healthcare infrastructure, particularly in emerging economies such as India and China.
The market is segmented into key countries: China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The demand for blood transfusions is on the rise due to the growing prevalence of chronic illnesses, which necessitate more frequent blood donations. Enhanced healthcare facilities and government initiatives aimed at promoting voluntary blood donation are also contributing to increased donor participation. Public awareness campaigns are crucial in educating the population about the importance of blood donation, thereby improving the overall blood supply.
Technological advancements in blood separation and storage are further enhancing the efficiency and safety of blood component usage. The rise in surgical procedures across the region is another factor contributing to market expansion. Additionally, international health organizations are providing support and fostering collaborations to improve blood banking systems, which is vital for the market's development.
Market Segmentation Analysis
The Asia Pacific donor blood component market is categorized based on various parameters:
The Asia Pacific donor blood component market is witnessing a surge in donor awareness, which is crucial for increasing voluntary participation and repeat donations. Educational campaigns are essential in dispelling myths surrounding blood donation and highlighting its life-saving impact. Public health initiatives, celebrity endorsements, and community efforts are instrumental in promoting voluntary blood donation. For instance, the World Health Organization celebrated the 20th anniversary of World Blood Donor Day in 2024, emphasizing the importance of donor appreciation and encouraging global participation.
In India, Ahmedabad has emerged as a leader in blood donation campaigns, boasting a remarkable number of centurion donors—individuals who have donated blood over 100 times. The Indian Red Cross Society's efforts in organizing blood donation camps have resulted in the collection of over 250,000 units in 2023, showcasing the community's commitment to voluntary blood donation. Such initiatives underline the significance of raising awareness among potential donors to ensure a stable blood supply, which is vital for the market's growth.
Country Insights
By country, China holds the largest share of the Asia Pacific donor blood component market. The implementation of the 1998 Blood Donation Law established a voluntary, unpaid donation system, encouraging healthy citizens aged 18 to 55 to donate blood. The government covers all costs related to blood collection, testing, and processing, ensuring safety and ethical standards. In 2023, China recorded approximately 16.99 million voluntary blood donations, reflecting the success of national campaigns and public awareness efforts.
Fresenius Kabi China has been actively promoting blood donation among youth, engaging thousands of participants and collecting significant amounts of blood over the years. The increasing aging population and the rise in chronic diseases in China are driving the demand for blood components, further supporting market growth.
Company Profiles
Key players in the Asia Pacific donor blood component market include Vitalant, Memorial Sloan Kettering Cancer Center, Roswell Park Comprehensive Cancer Center, Policlinico of Milan, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, and Tata Memorial Hospital. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
The market is segmented into key countries: China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The demand for blood transfusions is on the rise due to the growing prevalence of chronic illnesses, which necessitate more frequent blood donations. Enhanced healthcare facilities and government initiatives aimed at promoting voluntary blood donation are also contributing to increased donor participation. Public awareness campaigns are crucial in educating the population about the importance of blood donation, thereby improving the overall blood supply.
Technological advancements in blood separation and storage are further enhancing the efficiency and safety of blood component usage. The rise in surgical procedures across the region is another factor contributing to market expansion. Additionally, international health organizations are providing support and fostering collaborations to improve blood banking systems, which is vital for the market's development.
Market Segmentation Analysis
The Asia Pacific donor blood component market is categorized based on various parameters:
- By Blood Component: The market is divided into Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others. Red Blood Cells are expected to hold the largest market share in 2024.
- By Blood Component Volume: Similar to the above, Red Blood Cells dominate this segment as well.
- By Indication: The market is segmented into Immunosuppression and Oncology, with Immunosuppression holding the largest share in 2024.
- By Immunosuppression: This includes categories such as Organ Transplant, HIV/AIDS, Autoimmune Diseases, Cardiovascular Surgeries, and Orthopedic Surgeries, with HIV/AIDS being the largest segment.
- By Oncology: The market is divided into Hematologic Malignancies and Solid Tumor Patients, with Hematologic Malignancies leading in market share.
- By Application: Applications include Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others, with Anemia Management being the most significant.
- By Age Group: The market is segmented into Adult and Child, with Adults holding the largest share.
- By End User: This includes Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others, with Hospitals being the primary end user.
The Asia Pacific donor blood component market is witnessing a surge in donor awareness, which is crucial for increasing voluntary participation and repeat donations. Educational campaigns are essential in dispelling myths surrounding blood donation and highlighting its life-saving impact. Public health initiatives, celebrity endorsements, and community efforts are instrumental in promoting voluntary blood donation. For instance, the World Health Organization celebrated the 20th anniversary of World Blood Donor Day in 2024, emphasizing the importance of donor appreciation and encouraging global participation.
In India, Ahmedabad has emerged as a leader in blood donation campaigns, boasting a remarkable number of centurion donors—individuals who have donated blood over 100 times. The Indian Red Cross Society's efforts in organizing blood donation camps have resulted in the collection of over 250,000 units in 2023, showcasing the community's commitment to voluntary blood donation. Such initiatives underline the significance of raising awareness among potential donors to ensure a stable blood supply, which is vital for the market's growth.
Country Insights
By country, China holds the largest share of the Asia Pacific donor blood component market. The implementation of the 1998 Blood Donation Law established a voluntary, unpaid donation system, encouraging healthy citizens aged 18 to 55 to donate blood. The government covers all costs related to blood collection, testing, and processing, ensuring safety and ethical standards. In 2023, China recorded approximately 16.99 million voluntary blood donations, reflecting the success of national campaigns and public awareness efforts.
Fresenius Kabi China has been actively promoting blood donation among youth, engaging thousands of participants and collecting significant amounts of blood over the years. The increasing aging population and the rise in chronic diseases in China are driving the demand for blood components, further supporting market growth.
Company Profiles
Key players in the Asia Pacific donor blood component market include Vitalant, Memorial Sloan Kettering Cancer Center, Roswell Park Comprehensive Cancer Center, Policlinico of Milan, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, and Tata Memorial Hospital. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. DONOR BLOOD COMPONENT MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
4.4 Global Disease Prevalence of 5 Key Diseases, 2024
5. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. DONOR BLOOD COMPONENT MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Donor Blood Component Market Forecast and Analysis
7. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY BLOOD COMPONENT
7.1 Red Blood Cells
7.1.1 Overview
7.1.2 Red Blood Cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 White blood cells
7.2.1 Overview
7.2.2 White blood cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Platelets
7.3.1 Overview
7.3.2 Platelets: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Plasma
7.4.1 Overview
7.4.2 Plasma: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY BLOOD COMPONENT VOLUME
8.1 Red Blood Cells
8.1.1 Overview
8.1.2 Red Blood Cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 White blood cells
8.2.1 Overview
8.2.2 White blood cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Platelets
8.3.1 Overview
8.3.2 Platelets: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Plasma
8.4.1 Overview
8.4.2 Plasma: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY INDICATION
9.1 Immunosuppression
9.1.1 Overview
9.1.2 Immunosuppression: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oncology
9.2.1 Overview
9.2.2 Oncology: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY IMMUNOSUPPRESSION
10.1 Organ Transplant
10.1.1 Overview
10.1.2 Organ Transplant: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 HIV or AIDS
10.2.1 Overview
10.2.2 HIV or AIDS: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Autoimmune Disease
10.3.1 Overview
10.3.2 Autoimmune Disease: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Cardiovascular Surgeries
10.4.1 Overview
10.4.2 Cardiovascular Surgeries: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Orthopedic Surgeries
10.5.1 Overview
10.5.2 Orthopedic Surgeries: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY ONCOLOGY
11.1 Hematologic malignancies
11.1.1 Overview
11.1.2 Hematologic malignancies: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Solid Tumor Patients
11.2.1 Overview
11.2.2 Solid Tumor Patients: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY APPLICATION
12.1 Anemia management
12.1.1 Overview
12.1.2 Anemia management: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Thrombocytopenia treatment
12.2.1 Overview
12.2.2 Thrombocytopenia treatment: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Coagulopathy correction
12.3.1 Overview
12.3.2 Coagulopathy correction: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.4 Supportive care during chemotherapy
12.4.1 Overview
12.4.2 Supportive care during chemotherapy: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.5 Surgery
12.5.1 Overview
12.5.2 Surgery: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.6 Others
12.6.1 Overview
12.6.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY AGE GROUP
13.1 Adult
13.1.1 Overview
13.1.2 Adult: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Child
13.2.1 Overview
13.2.2 Child: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY END USER
14.1 Hospitals
14.1.1 Overview
14.1.2 Hospitals: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Oncology centers
14.2.1 Overview
14.2.2 Oncology centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Transplant centers
14.3.1 Overview
14.3.2 Transplant centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.4 Ambulatory surgical centers
14.4.1 Overview
14.4.2 Ambulatory surgical centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.5 Others
14.5.1 Overview
14.5.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET - COUNTRY ANALYSIS
15.1 Asia Pacific
15.1.1 Asia Pacific Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.1.1 Asia Pacific Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.2.2 China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 China: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.1.2.2.2 China: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.1.2.2.3 China: Asia Pacific Donor Blood Component Market Share - by Indication
15.1.2.2.4 China: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.1.2.2.5 China: Asia Pacific Donor Blood Component Market Share - by Oncology
15.1.2.2.6 China: Asia Pacific Donor Blood Component Market Share - by Application
15.1.2.2.7 China: Asia Pacific Donor Blood Component Market Share - by Age Group
15.1.2.2.8 China: Asia Pacific Donor Blood Component Market Share - by End User
15.2.3.3 Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Japan: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.2.3.3.2 Japan: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.2.3.3.3 Japan: Asia Pacific Donor Blood Component Market Share - by Indication
15.2.3.3.4 Japan: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.2.3.3.5 Japan: Asia Pacific Donor Blood Component Market Share - by Oncology
15.2.3.3.6 Japan: Asia Pacific Donor Blood Component Market Share - by Application
15.2.3.3.7 Japan: Asia Pacific Donor Blood Component Market Share - by Age Group
15.2.3.3.8 Japan: Asia Pacific Donor Blood Component Market Share - by End User
15.3.4.4 India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 India: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.3.4.4.2 India: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.3.4.4.3 India: Asia Pacific Donor Blood Component Market Share - by Indication
15.3.4.4.4 India: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.3.4.4.5 India: Asia Pacific Donor Blood Component Market Share - by Oncology
15.3.4.4.6 India: Asia Pacific Donor Blood Component Market Share - by Application
15.3.4.4.7 India: Asia Pacific Donor Blood Component Market Share - by Age Group
15.3.4.4.8 India: Asia Pacific Donor Blood Component Market Share - by End User
15.4.5.5 Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.4.5.5.1 Australia: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.4.5.5.2 Australia: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.4.5.5.3 Australia: Asia Pacific Donor Blood Component Market Share - by Indication
15.4.5.5.4 Australia: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.4.5.5.5 Australia: Asia Pacific Donor Blood Component Market Share - by Oncology
15.4.5.5.6 Australia: Asia Pacific Donor Blood Component Market Share - by Application
15.4.5.5.7 Australia: Asia Pacific Donor Blood Component Market Share - by Age Group
15.4.5.5.8 Australia: Asia Pacific Donor Blood Component Market Share - by End User
15.5.6.6 South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.5.6.6.1 South Korea: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.5.6.6.2 South Korea: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.5.6.6.3 South Korea: Asia Pacific Donor Blood Component Market Share - by Indication
15.5.6.6.4 South Korea: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.5.6.6.5 South Korea: Asia Pacific Donor Blood Component Market Share - by Oncology
15.5.6.6.6 South Korea: Asia Pacific Donor Blood Component Market Share - by Application
15.5.6.6.7 South Korea: Asia Pacific Donor Blood Component Market Share - by Age Group
15.5.6.6.8 South Korea: Asia Pacific Donor Blood Component Market Share - by End User
15.6.7.7 Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.6.7.7.1 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.6.7.7.2 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.6.7.7.3 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Indication
15.6.7.7.4 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.6.7.7.5 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Oncology
15.6.7.7.6 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Application
15.6.7.7.7 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Age Group
15.6.7.7.8 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by End User
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Vitalant
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Memorial Sloan Kettering Cancer Center
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 Roswell Park Comprehensive Cancer Center
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 Policlinico of Milan
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 MD Anderson Cancer Center.
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 The Johns Hopkins Hospital
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 The Royal Marsden
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Gustave Roussy
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Peter MacCallum Cancer Centre
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
18.10 Tata Memorial Hospital
18.10.1 Key Facts
18.10.2 Business Description
18.10.3 Products and Services
18.10.4 Financial Overview
18.10.5 SWOT Analysis
18.10.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. DONOR BLOOD COMPONENT MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
4.4 Global Disease Prevalence of 5 Key Diseases, 2024
5. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. DONOR BLOOD COMPONENT MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Donor Blood Component Market Forecast and Analysis
7. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY BLOOD COMPONENT
7.1 Red Blood Cells
7.1.1 Overview
7.1.2 Red Blood Cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 White blood cells
7.2.1 Overview
7.2.2 White blood cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Platelets
7.3.1 Overview
7.3.2 Platelets: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Plasma
7.4.1 Overview
7.4.2 Plasma: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY BLOOD COMPONENT VOLUME
8.1 Red Blood Cells
8.1.1 Overview
8.1.2 Red Blood Cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 White blood cells
8.2.1 Overview
8.2.2 White blood cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Platelets
8.3.1 Overview
8.3.2 Platelets: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Plasma
8.4.1 Overview
8.4.2 Plasma: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY INDICATION
9.1 Immunosuppression
9.1.1 Overview
9.1.2 Immunosuppression: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oncology
9.2.1 Overview
9.2.2 Oncology: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY IMMUNOSUPPRESSION
10.1 Organ Transplant
10.1.1 Overview
10.1.2 Organ Transplant: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 HIV or AIDS
10.2.1 Overview
10.2.2 HIV or AIDS: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Autoimmune Disease
10.3.1 Overview
10.3.2 Autoimmune Disease: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Cardiovascular Surgeries
10.4.1 Overview
10.4.2 Cardiovascular Surgeries: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Orthopedic Surgeries
10.5.1 Overview
10.5.2 Orthopedic Surgeries: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY ONCOLOGY
11.1 Hematologic malignancies
11.1.1 Overview
11.1.2 Hematologic malignancies: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Solid Tumor Patients
11.2.1 Overview
11.2.2 Solid Tumor Patients: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY APPLICATION
12.1 Anemia management
12.1.1 Overview
12.1.2 Anemia management: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Thrombocytopenia treatment
12.2.1 Overview
12.2.2 Thrombocytopenia treatment: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Coagulopathy correction
12.3.1 Overview
12.3.2 Coagulopathy correction: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.4 Supportive care during chemotherapy
12.4.1 Overview
12.4.2 Supportive care during chemotherapy: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.5 Surgery
12.5.1 Overview
12.5.2 Surgery: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.6 Others
12.6.1 Overview
12.6.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY AGE GROUP
13.1 Adult
13.1.1 Overview
13.1.2 Adult: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Child
13.2.1 Overview
13.2.2 Child: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY END USER
14.1 Hospitals
14.1.1 Overview
14.1.2 Hospitals: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Oncology centers
14.2.1 Overview
14.2.2 Oncology centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Transplant centers
14.3.1 Overview
14.3.2 Transplant centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.4 Ambulatory surgical centers
14.4.1 Overview
14.4.2 Ambulatory surgical centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.5 Others
14.5.1 Overview
14.5.2 Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. ASIA PACIFIC DONOR BLOOD COMPONENT MARKET - COUNTRY ANALYSIS
15.1 Asia Pacific
15.1.1 Asia Pacific Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.1.1 Asia Pacific Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.2.2 China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 China: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.1.2.2.2 China: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.1.2.2.3 China: Asia Pacific Donor Blood Component Market Share - by Indication
15.1.2.2.4 China: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.1.2.2.5 China: Asia Pacific Donor Blood Component Market Share - by Oncology
15.1.2.2.6 China: Asia Pacific Donor Blood Component Market Share - by Application
15.1.2.2.7 China: Asia Pacific Donor Blood Component Market Share - by Age Group
15.1.2.2.8 China: Asia Pacific Donor Blood Component Market Share - by End User
15.2.3.3 Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Japan: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.2.3.3.2 Japan: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.2.3.3.3 Japan: Asia Pacific Donor Blood Component Market Share - by Indication
15.2.3.3.4 Japan: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.2.3.3.5 Japan: Asia Pacific Donor Blood Component Market Share - by Oncology
15.2.3.3.6 Japan: Asia Pacific Donor Blood Component Market Share - by Application
15.2.3.3.7 Japan: Asia Pacific Donor Blood Component Market Share - by Age Group
15.2.3.3.8 Japan: Asia Pacific Donor Blood Component Market Share - by End User
15.3.4.4 India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 India: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.3.4.4.2 India: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.3.4.4.3 India: Asia Pacific Donor Blood Component Market Share - by Indication
15.3.4.4.4 India: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.3.4.4.5 India: Asia Pacific Donor Blood Component Market Share - by Oncology
15.3.4.4.6 India: Asia Pacific Donor Blood Component Market Share - by Application
15.3.4.4.7 India: Asia Pacific Donor Blood Component Market Share - by Age Group
15.3.4.4.8 India: Asia Pacific Donor Blood Component Market Share - by End User
15.4.5.5 Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.4.5.5.1 Australia: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.4.5.5.2 Australia: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.4.5.5.3 Australia: Asia Pacific Donor Blood Component Market Share - by Indication
15.4.5.5.4 Australia: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.4.5.5.5 Australia: Asia Pacific Donor Blood Component Market Share - by Oncology
15.4.5.5.6 Australia: Asia Pacific Donor Blood Component Market Share - by Application
15.4.5.5.7 Australia: Asia Pacific Donor Blood Component Market Share - by Age Group
15.4.5.5.8 Australia: Asia Pacific Donor Blood Component Market Share - by End User
15.5.6.6 South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.5.6.6.1 South Korea: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.5.6.6.2 South Korea: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.5.6.6.3 South Korea: Asia Pacific Donor Blood Component Market Share - by Indication
15.5.6.6.4 South Korea: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.5.6.6.5 South Korea: Asia Pacific Donor Blood Component Market Share - by Oncology
15.5.6.6.6 South Korea: Asia Pacific Donor Blood Component Market Share - by Application
15.5.6.6.7 South Korea: Asia Pacific Donor Blood Component Market Share - by Age Group
15.5.6.6.8 South Korea: Asia Pacific Donor Blood Component Market Share - by End User
15.6.7.7 Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.6.7.7.1 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Blood Component
15.6.7.7.2 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Blood Component Volume
15.6.7.7.3 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Indication
15.6.7.7.4 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Immunosuppression
15.6.7.7.5 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Oncology
15.6.7.7.6 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Application
15.6.7.7.7 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by Age Group
15.6.7.7.8 Rest of APAC: Asia Pacific Donor Blood Component Market Share - by End User
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Vitalant
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Memorial Sloan Kettering Cancer Center
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 Roswell Park Comprehensive Cancer Center
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 Policlinico of Milan
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 MD Anderson Cancer Center.
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 The Johns Hopkins Hospital
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 The Royal Marsden
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Gustave Roussy
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Peter MacCallum Cancer Centre
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
18.10 Tata Memorial Hospital
18.10.1 Key Facts
18.10.2 Business Description
18.10.3 Products and Services
18.10.4 Financial Overview
18.10.5 SWOT Analysis
18.10.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
LIST OF TABLES
Table 1. Asia Pacific Donor Blood Component Market Segmentation
Table 3. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 5. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 6. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 7. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 8. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 9. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 11. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 12. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 14. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 15. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 16. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 17. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 18. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 20. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 22. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 23. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 24. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 25. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 26. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 27. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 28. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 30. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 31. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 32. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 33. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 34. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 35. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 36. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 37. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 38. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 39. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 40. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 41. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 42. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 43. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 44. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 45. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 46. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 47. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 48. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 49. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 50. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 51. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 52. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 53. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 54. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 55. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 56. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 57. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 58. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 59. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 60. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 1. Asia Pacific Donor Blood Component Market Segmentation
Table 3. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 5. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 6. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 7. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 8. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 9. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 11. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 12. Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 14. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 15. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 16. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 17. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 18. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 20. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 22. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 23. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 24. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 25. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 26. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 27. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 28. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 30. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 31. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 32. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 33. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 34. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 35. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 36. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 37. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 38. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 39. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 40. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 41. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 42. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 43. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 44. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 45. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 46. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 47. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 48. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 49. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 50. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 51. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 52. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 53. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 54. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 55. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 56. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 57. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 58. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 59. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 60. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
LIST OF FIGURES
Figure 1. Asia Pacific Donor Blood Component Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Asia Pacific Donor Blood Component Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Donor Blood Component Market Share (%) - by Blood Component, 2024 and 2031
Figure 8. Red Blood Cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. White blood cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Platelets: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Plasma: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Asia Pacific Donor Blood Component Market Share (%) - by Blood Component Volume, 2024 and 2031
Figure 14. Red Blood Cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. White blood cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Platelets: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Plasma: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Asia Pacific Donor Blood Component Market Share (%) - by Indication, 2024 and 2031
Figure 20. Immunosuppression: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Oncology: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Asia Pacific Donor Blood Component Market Share (%) - by Immunosuppression, 2024 and 2031
Figure 23. Organ Transplant: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. HIV or AIDS: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Autoimmune Disease: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Cardiovascular Surgeries: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Orthopedic Surgeries: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Asia Pacific Donor Blood Component Market Share (%) - by Oncology, 2024 and 2031
Figure 30. Hematologic malignancies: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Solid Tumor Patients: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Asia Pacific Donor Blood Component Market Share (%) - by Application, 2024 and 2031
Figure 33. Anemia management: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Thrombocytopenia treatment: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Coagulopathy correction: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Supportive care during chemotherapy: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Surgery: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Asia Pacific Donor Blood Component Market Share (%) - by Age Group, 2024 and 2031
Figure 40. Adult: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Child: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Asia Pacific Donor Blood Component Market Share (%) - by End User, 2024 and 2031
Figure 43. Hospitals: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 44. Oncology centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Transplant centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Ambulatory surgical centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 48. Asia Pacific Donor Blood Component Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 49. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 52. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 1. Asia Pacific Donor Blood Component Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Asia Pacific Donor Blood Component Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Donor Blood Component Market Share (%) - by Blood Component, 2024 and 2031
Figure 8. Red Blood Cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. White blood cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Platelets: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Plasma: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Asia Pacific Donor Blood Component Market Share (%) - by Blood Component Volume, 2024 and 2031
Figure 14. Red Blood Cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. White blood cells: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Platelets: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Plasma: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Asia Pacific Donor Blood Component Market Share (%) - by Indication, 2024 and 2031
Figure 20. Immunosuppression: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Oncology: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Asia Pacific Donor Blood Component Market Share (%) - by Immunosuppression, 2024 and 2031
Figure 23. Organ Transplant: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. HIV or AIDS: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Autoimmune Disease: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Cardiovascular Surgeries: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Orthopedic Surgeries: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Asia Pacific Donor Blood Component Market Share (%) - by Oncology, 2024 and 2031
Figure 30. Hematologic malignancies: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Solid Tumor Patients: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Asia Pacific Donor Blood Component Market Share (%) - by Application, 2024 and 2031
Figure 33. Anemia management: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Thrombocytopenia treatment: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Coagulopathy correction: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Supportive care during chemotherapy: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Surgery: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Asia Pacific Donor Blood Component Market Share (%) - by Age Group, 2024 and 2031
Figure 40. Adult: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Child: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Asia Pacific Donor Blood Component Market Share (%) - by End User, 2024 and 2031
Figure 43. Hospitals: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 44. Oncology centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Transplant centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Ambulatory surgical centers: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Others: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 48. Asia Pacific Donor Blood Component Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 49. China: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Japan: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. India: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 52. Australia: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. South Korea: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. Rest of APAC: Asia Pacific Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
